222 related articles for article (PubMed ID: 11145222)
41. Impact of amino acid replacements on in vitro permeation enhancement and cytotoxicity of the intestinal absorption promoter, melittin.
Maher S; Devocelle M; Ryan S; McClean S; Brayden DJ
Int J Pharm; 2010 Mar; 387(1-2):154-60. PubMed ID: 20025949
[TBL] [Abstract][Full Text] [Related]
42. Unconjugated bilirubin modulates the intestinal epithelial barrier function in a human-derived in vitro model.
Raimondi F; Crivaro V; Capasso L; Maiuri L; Santoro P; Tucci M; Barone MV; Pappacoda S; Paludetto R
Pediatr Res; 2006 Jul; 60(1):30-3. PubMed ID: 16690950
[TBL] [Abstract][Full Text] [Related]
43. The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system.
Nerurkar MM; Burton PS; Borchardt RT
Pharm Res; 1996 Apr; 13(4):528-34. PubMed ID: 8710741
[TBL] [Abstract][Full Text] [Related]
44. Size-dependent dextran transport across rat alveolar epithelial cell monolayers.
Matsukawa Y; Lee VH; Crandall ED; Kim KJ
J Pharm Sci; 1997 Mar; 86(3):305-9. PubMed ID: 9050797
[TBL] [Abstract][Full Text] [Related]
45. Bioactive self-assembling lipid-like peptides as permeation enhancers for oral drug delivery.
Karavasili C; Spanakis M; Papagiannopoulou D; Vizirianakis IS; Fatouros DG; Koutsopoulos S
J Pharm Sci; 2015 Jul; 104(7):2304-11. PubMed ID: 25994901
[TBL] [Abstract][Full Text] [Related]
46. Characteristics of the low density corneal endothelial monolayer.
Singh JS; Haroldson TA; Patel SP
Exp Eye Res; 2013 Oct; 115():239-45. PubMed ID: 23830909
[TBL] [Abstract][Full Text] [Related]
47. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Makhlof A; Werle M; Tozuka Y; Takeuchi H
J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935
[TBL] [Abstract][Full Text] [Related]
48. Confocal laser scanning microscopic visualization of the transport of dextrans after nasal administration to rats: effects of absorption enhancers.
Marttin E; Verhoef JC; Cullander C; Romeijn SG; Nagelkerke JF; Merkus FW
Pharm Res; 1997 May; 14(5):631-7. PubMed ID: 9165535
[TBL] [Abstract][Full Text] [Related]
49. A multi-chamber microfluidic intestinal barrier model using Caco-2 cells for drug transport studies.
Tan HY; Trier S; Rahbek UL; Dufva M; Kutter JP; Andresen TL
PLoS One; 2018; 13(5):e0197101. PubMed ID: 29746551
[TBL] [Abstract][Full Text] [Related]
50. Poly-L-arginine predominantly increases the paracellular permeability of hydrophilic macromolecules across rabbit nasal epithelium in vitro.
Ohtake K; Maeno T; Ueda H; Natsume H; Morimoto Y
Pharm Res; 2003 Feb; 20(2):153-60. PubMed ID: 12636152
[TBL] [Abstract][Full Text] [Related]
51. Cytotoxic effects of pamidronate on monolayers of human intestinal epithelial (Caco-2) cells and its epithelial transport.
Twiss IM; de Water R; den Hartigh J; Sparidans R; Ramp-Koopmanschap W; Brill H; Wijdeveld M; Vermeij P
J Pharm Sci; 1994 May; 83(5):699-703. PubMed ID: 8071824
[TBL] [Abstract][Full Text] [Related]
52. A novel tool to characterize paracellular transport: the APTS-dextran ladder.
Neuhaus W; Bogner E; Wirth M; Trzeciak J; Lachmann B; Gabor F; Noe CR
Pharm Res; 2006 Jul; 23(7):1491-501. PubMed ID: 16779707
[TBL] [Abstract][Full Text] [Related]
53. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
54. NC-1059: a channel-forming peptide that modulates drug delivery across in vitro corneal epithelium.
Martin J; Malreddy P; Iwamoto T; Freeman LC; Davidson HJ; Tomich JM; Schultz BD
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3337-45. PubMed ID: 19234338
[TBL] [Abstract][Full Text] [Related]
55. Intestinal Drug Absorption Enhancement by
Haasbroek A; Willers C; Glyn M; du Plessis L; Hamman J
Pharmaceutics; 2019 Jan; 11(1):. PubMed ID: 30669246
[TBL] [Abstract][Full Text] [Related]
56. Correlation of in vitro cytotoxicity with paracellular permeability in mortal rat intestinal cells.
Konsoula R; Barile FA
J Pharmacol Toxicol Methods; 2007; 55(2):176-83. PubMed ID: 16891127
[TBL] [Abstract][Full Text] [Related]
57. Role of 99mTc-mannitol and 99mTc-PEG in the assessment of paracellular integrity of cell monolayers.
Shah PJ; Jogani VV; Mishra P; Mishra AK; Bagchi T; Misra AR
Nucl Med Commun; 2007 Aug; 28(8):653-9. PubMed ID: 17625388
[TBL] [Abstract][Full Text] [Related]
58. Surfactants enhance the tight-junction permeability of food allergens in human intestinal epithelial Caco-2 cells.
Mine Y; Zhang JW
Int Arch Allergy Immunol; 2003 Feb; 130(2):135-42. PubMed ID: 12673067
[TBL] [Abstract][Full Text] [Related]
59. Protective effects of lactoferrin against intestinal mucosal damage induced by lipopolysaccharide in human intestinal Caco-2 cells.
Hirotani Y; Ikeda K; Kato R; Myotoku M; Umeda T; Ijiri Y; Tanaka K
Yakugaku Zasshi; 2008 Sep; 128(9):1363-8. PubMed ID: 18758152
[TBL] [Abstract][Full Text] [Related]
60. Effect of adrenergic stimulation on drug absorption via passive diffusion in Caco-2 cells.
Kimoto T; Takanashi M; Mukai H; Ogawara K; Kimura T; Higaki K
Int J Pharm; 2009 Feb; 368(1-2):31-6. PubMed ID: 18977284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
